ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
 

ANZMTG 01.09 RTN2 Trial - A Randomised Trial of Post-Operative Radiation Therapy Following Wide Excision

Neurotropism, defined as invasion by melanoma of peripheral neural tissue, is uncommon but it is this feature which is linked with a high risk of the cancer coming back in the same area. The primary aim of this trial is to determine if there is a difference in the rate of relapse between 2 randomised groups of patients treated after surgery with either radiation therapy or initial observation.

Principal Investigator's details:
Dr Matthew Foote
Princess Alexandria Hospital
Email: matthew_foote@health.qld.gov.au

Study status - Open to recruitment
ANZ Clinical Trials Registry number - ACTRN12609000351213
ClinicalTrials.gov identifier - NCT00975520

ANZMTG details:
Email: anzmtg0109@melanoma.org.au
Phone: +61 2 9911 7352


Return to Previous Page